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ABSTRACT 
 
Traumatic brain injury (TBI) is a common cause of mortality and morbidity 
among civilians and servicemen alike. The spectrum of TBIs encompasses mild to severe 
cases, with the predominate number of TBIs being mild (mTBI). Combat-related TBI 
inflicted by explosive blast (bTBI) is highly prevalent among military personnel. The 
injurious environment caused by explosive blast includes the high-energy shock wave that 
dissipates energy at the boundaries of anatomical structures with distinct acoustical 
impedance, and the blast wind that can propel the body resulting in acceleration/ 
deceleration type of injury. mTBI can also occur in the civilian population often as a result 
of contact sports and because of the mild acute symptoms it is often repeated. mTBI causes 
transient mood and cognitive changes, but it may also increase the risk for late onset 
chronic neurodegenerative conditions such as chronic traumatic encephalopathy. Little is 
known about the mechanism of mTBI and its post-sequelae. Monoamine projections from 
the brainstem play a key role in modulating the forebrain regions, and galanin, a 
neuropeptide that, in the rat, is co-localised with two of these key neurotransmitters. 
Dysfunctions in these systems have been associated with mood/anxiety disorders.  
 
In this thesis we set out to examine changes in the monoamine and galanin 
systems following single and repeated blast exposure, in male and female rats. mTBI was 
induced using an experimental blast tube which uses real explosives. For one of the studies 
a shock tube that uses compressed air was also used to produce a blast-induced mTBI 
(mbTBI). The models appeared to cause mbTBI, given that no injury was observed when 
staining for degeneration, blood vessel damage, or disruption to the white matter tracts in 
either model, following single or repeated exposure.  
 
The noradrenaline (NA) system was found to be particularly sensitive to 
mbTBI. The transcript levels of the biosynthetic enzyme tyrosine hydroxylase (TH) were 
found elevated immediately post-exposure bilaterally in the locus coeruleus (LC) in both 
males and females. This was concurrent with a transient increase in NA levels in a number 
of forebrain regions, and translated into decreased immobility in the forced swim test. This 
was only explored in the males and using the blast tube.   
 
Sex-specific differences were found in the serotonin system (5-HT). Here the 
transcript levels of the biosynthetic enzyme tryptophan hydroxylase 2 (TPH2), were 
elevated across the mid/caudal-rostral dorsal raphe nucleus (DRN) in females. The 
elevation occurred acutely post-TBI and remained even after day (D)7, the last time point 
evaluated. In the males TPH2 was similarly elevated, but more modestly and only 
transiently. The increase was limited to only the mid/caudal part of the DRN, and by D3 
TPH2 levels were similar to levels detected in sham animals. No changes in 5-HT levels 
were seen in the forebrain regions of male rats.  
 
   
Exposure induced changes in the expression of galanin and its receptors were 
also examined by in situ hybridisation but in males only. Galanin mRNA levels increased 
bilaterally in the LC and gradually in the mid/caudal, but not in the rostral DRN and 
remained elevated, even at D7 in both nuclei.. However, quantitative polymerase chain 
reaction only confirmed the acute galanin increase in the LC, and in addition revealed 
galanin transcripts in the hippocampus. In terms of the galanin receptor 1-3 (GalR1-3), 
GalR1 was increased in the ventral periaqueductal grey and this increase persisted at D7 
post-TBI, at this time-point GalR2 was decreased. In the forebrain regions GalR3 appeared 
to be the most dynamic receptor, decreasing in most regions immediately following TBI, 
and recovering on D7 post-exposure, except in the ventral hippocampus, where changes 
persisted.  
 
A cumulative effect of repeated exposure to blast was not apparent in the 
levels of the transcripts for TH, TPH2, and galanin using either the blast or shock tube in 
male rodents. 
 
Serum analyses revealed sex-specific differences acutely following a single 
blast exposure, including an increase in corticosterone and substance P in female and 
decreased BDNF levels in male exposed rats. 
 
Taken together, these findings indicate a role for both the monoamine and the 
galanin systems following blast exposure, these changes appear robust across models and 
sexes (although some sex-specific differences are apparent). Hence these systems are 
possibly mediators of post-TBI sequelae and targeting the persistent dysfunctions in these 
systems may bring about therapeutic benefits. 
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1 INTRODUCTION  
 
1.1 Traumatic Brain Injury 
 
1.1.1 Blast-related TBI 
 
Traumatic brain injury (TBI) sustained during military-related combat in recent 
conflicts has largely been a result of explosive devices including: artillery, mines, booby 
traps, aerial bombs, improvised explosive devices, and rocket propelled grenades (Warden, 
2006). In previous wars exposure to such weaponry would have likely resulted in death. 
Improvements in body armour and on the front-line medical care have increased survival 
rates (Okie, 2005; Purim-Shem-Tov et al., 2013). While the protective gear effectively 
shields a soldier from shrapnel and bullets, it cannot completely protect against the face, 
neck, and closed head injuries, typical of a blast exposure (Xydakis et al., 2005). In fact, 
studies estimate that approximately 56-78% of head injuries inflicted in the current wars were 
a result of blast exposure (Murray et al., 2005; Sayer et al., 2008). TBI in this context is 
termed blast-induced TBI (bTBI), which is a complex incident and can be divided into a 
number of events (Figure 1.1). 
 
The instantaneous conversion of an explosive into gas during a detonation 
results in rapid changes in atmospheric pressure. Initially, there is an immediate increase in 
pressure due to heating and accelerating of air molecules, followed by a sudden drop 
(Katherine H. Taber et al., 2014; Moore and Jaffee, 2010). These extreme pressure changes 
can result in the primary injury when the blast wave reaches the body, an initial burst of 
energy can be transmitted through the head and into the brain (Risling and Davidsson, 2012). 
Secondary injury can be caused by the force of the blast winds, which can propel shrapnel 
and other fragments into motion with considerable force. Impact to the head can result in 
either blunt force or penetrating injury to the brain. Tertiary injuries occur as a result of the 
kinetic energy generated and released by the blast wind, which accelerates the body. Once the 
body comes to a stop, the brain continues to move in the direction of the force and thus 
collides with the tough skull bone, shearing and diffuse injuries likely results. Finally, 
quaternary injuries can include flash burns and breathing in noxious gases associated with 
the explosion (Cernak, 2010; Risling and Davidsson, 2012). Additionally, blast exposure is 
systemic and impacts the whole body, thus air emboli can form in the blood vessels 
elsewhere and be transported up to the brain (Cernak, 2010; Guy et al., 2000). 
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Figure 1.1 Blast-related TBI. a) Sequence of changes in atmospheric pressure following a detonation. (b-d) 
Schematic representation of the different injury mechanisms following blast exposure.  
 
 
 
 
1.1.2 Use of animal models  
The aforementioned series of injuries seldom occur in isolation, and in a 
battlefield situation it can be extremely difficult to ascertain the different injury mechanisms. 
Moreover, clinically we have limited knowledge about how the physics of a blast exposure 
interacts with a biological system.  Here the use of animal models can be quite beneficial. 
The models can be used to recapitulate the different injury mechanism following a blast 
exposure in a reproducible manner, allowing researchers to study and dissect each 
mechanism of injury independently. Animal models therefore enable researchers to tackle the 
complexity and multifaceted nature of a blast exposure in amenable steps.  
 
There are some obvious caveats to using animal models, particularly rodents. 
There are questions about scalability given rodents’ brains compared with our gyrencephalic 
ones, which likely differ in interacting with a blast wave. Furthermore, the biological clock in 
rodents is significantly different to humans. These limitations need to be considered when 
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attempting to translate findings across rodent models to humans. However, several factors 
have made rodents the model of choice, including cost-effectiveness, ability to manipulate 
and intervene with the disease progression, and availability of numerous behavioural assays, 
as well as, especially for the mouse, to generate genetically manipulated animals.  
 
Two of the most commonly used animal models to reproduce a segment of the 
blast-induced TBI, the primary blast wave exposure, are the shock tube and blast tube. The 
shock tube is comprised of a compression and expansion chamber, separated by mylar 
membranes of varying thickness. Once air or helium are pressurised in the compression 
chamber above the threshold of the designated mylar membrane(s), it ruptures and results in a 
pressure wave inside the expansion chamber (Long et al., 2009a; Ning and Zhou, 2015). The 
blast tube uses real explosives as the driver, and upon detonation a blast wave is propagated 
(Clemedson and Criborn, 1955).  
 
The interaction between a rapidly propagating, high-energy blast wave and the 
brain’s varying structure and density is likely to mean exposure to the primary blast wave 
alone and can trigger an array of complex cellular and molecular changes. Indeed, findings 
from both models have revealed the brain’s vulnerability to the primary blast wave (Ahlers et 
al., 2012; Elder et al., 2014; Kamnaksh et al., 2012; Kwon et al., 2011; Risling et al., 2011; 
Wang et al., 2011). This thesis will focus on the primary blast exposure predominantly using 
the blast tube using rats, but the shock tube is also used. 
 
 
1.1.3 Classification of TBI 
 
TBI is a spectrum disorder, ranging between mild, moderate, and severe. In 
both the military and civilian population, the significant majority of TBIs (typically around 
85%) are mild in severity (mTBI) (Hyder et al., 2007). In the civilian population the majority 
of mTBI is a result of contact sports and is frequently referred to as concussion. mTBI and 
concussion are often used interchangeably. The most common tests used to identify the 
severity of a brain injury are:  
I. the Glasgow Coma Scale (GCS), which assesses best eye, verbal and motor 
responses 
II. any decreased or Loss of Consciousness (LOC) caused by the injury  
III. any Alterations in Consciousness (AOC) 
IV. alterations in memory immediately preceding or after the event, termed 
Post-traumatic Amnesia (PTA).  
 
A mild TBI is characterised by a GCS score of 13 to 15 (Figure 1.2), LOC of 
up to but not exceeding 30 minutes, and AOC and PTA for less than 24 hours (CDC, 2003; 
Teasdale and Jennett, 1974; VA/DoD, 2009). But these tools do not provide objective 
evidence of brain injury and are thus poor correlates of injury progression or recovery. In 
addition, common neuroimaging scans such as computed tomography (CT) are almost always 
normal i.e. currently there are no detectable structural changes in the brain post-trauma with 
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the diagnostic tools readily available to physicians. Hence, making mTBI diagnosis 
particularly challenging and reliant on patient re-call, which is often biased and incomplete 
(Drake et al., 2010). 
 
In the military setting, new tools have been developed in the form of 
neuropsychological testing to aid in the diagnosis of mTBI in soldiers  (Reeves et al., 2007). 
As of 2008 the United States Armed Forces requires service members to complete 
neuropsychological tests pre-deployment to ascertain their baseline neurocognitive 
evaluations using an Automated Neuropsychological Assessment Metric (ANAM) (VA/DoD, 
2009). ANAM can be re-administered following injury. If scores are compared to the 
baseline, impairments can be identified (and hence concussed from non-concussed 
individuals). Following a possible injury, the military acute concussion evaluation (MACE), 
(another screening tool) can also be used immediately in theatre, administered by a skilled 
practitioner. Initial evaluations of these screening tools for detecting concussion in soldiers 
looks promising, particularly the use of ANAM (Kelly et al., 2012).   
 
 
 
Figure 1.2 The Glasgow Coma Scale comprising of three tests: eye, verbal, and motor responses. The sum of the 
lowest possible GCS is 3 (deep coma or death), while the highest is 15 (fully awake person).   
 
 
 
Score
Spontaneous 4
Opens to verbal command 3
Opens to pain 2
No response 1
Orientated to time, place 
and person
5
Confused/disorientated 4
Inappropriate responses 3
Incomprehensible speech 2
No response 1
Obeys commands 6
Moves to localised pain 5
Withdraws from pain 4
Abnormal flexion 3
Abnormal extension 2
No response 1
Glasgow Coma Scale 
Best eye 
response
Best verbal 
response
Best motor 
response
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1.1.4 Post-concussive symptoms 
Following a mTBI/concussion a wide spectrum of neurobehavioural symptoms can 
develop, which can have acute onset and be transient, or develop over time and become more 
chronic (Marion et al., 2011). While for the majority of those who suffer a mTBI there are no 
symptoms past 24 hours, some 10-15% have lingering symptoms which persist months or 
years post-injury (Tanielian et al., 2008; VA/DoD, 2009). These symptoms largely fall into 
three categories: emotional, cognitive, and somatic disturbances, and are collectively referred 
to as post-concussive syndrome (PCS). A detailed list of categorised symptoms is shown in 
Figure 1.3. PCS can adversely affect the performance and overall quality of life of an affected 
individual and is a source of morbidity.  
Descriptions of lingering symptoms following blast exposure that left soldiers dazed 
and confused, with no physical evidence of external trauma to the head, were described and 
met with considerable interest in the early twentieth century, following World War I (WWI) 
(Mott, 1919; Myers, 1915). Shell-shock was one of the terms then coined referring to a 
syndrome that encompassed much of the symptomology that is part of PCS (Mott, 1919). 
This term was abandoned following an inauspicious report commissioned by the British 
Government, which declared shell-shock as a “convenient evasion of duty if not disguised 
malingering.”  
Concerns have since been renewed following several reports of persistent traumatic 
sequelae following a mTBI in both the military and sports populations (Colvin et al., 2009; 
Gardner and Yaffe, 2015; Kontos et al., 2013; Mendez et al., 2013; Rosenfeld and Ford, 
2010).  Some of the clinical aspects of PCS can be recapitulated in experimental models of 
blast-induced TBI using rodents, such as those relating to cognition (e.g. learning and 
memory) and emotional impairments (e.g. anxiety and depression) (Budde et al., 2013; 
Genovese et al., 2013; Heldt et al., 2014; Kamnaksh et al., 2012; Kwon et al., 2011). This 
thesis will focus on the emotional impairments following a blast exposure. 
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Figure 1.3 Emotional, cognitive, and somatic impairments reported following mTBI.  
 
1.1.5 Post-traumatic stress disorder 
Post-traumatic stress disorder (PTSD) is a complex disease triggered by exposure to 
extreme psychological stress, frequently without physical injury. Symptoms are commonly 
organised into four clusters and include avoidance symptoms, hyperarousal and reactivity, re-
experiencing phenomena, and mood and cognition impairments (Heim and Nemeroff, 2009; 
Pitman et al., 2012). PTSD involves substantial symptom overlap with PCS, and is 
commonly contaminant with mTBI in the military population (Hoge et al., 2004; Kennedy et 
al., 2010; Kok et al., 2012). 
Clinical studies suggest that PTSD prevalence is far higher in the military compared 
to the civilian population, and sustaining a TBI is a risk factor (Hoge et al., 2008; Kennedy et 
al., 2010; Kessler et al., 1995; Schneiderman et al., 2008). Interestingly, a study looking at the 
severity of injury and risk, found that PTSD is more prevalent in patients with a mTBI in 
comparison to individuals with more severe TBIs (Kennedy et al., 2010). The authors 
suggested that the lack of detectable physical injury and the vague and ambiguous trajectory 
of recovery in mTBI lead to increased onset of anxiety and other PTSD-related symptoms. 
Animal models have recapitulated some PTSD-related behavioural traits following repeated 
blast exposure. Exposed rats exhibited increased startle response, and increased anxiety six 
weeks post-exposure, concurrent with elevated stathmin 1 protein in the amygdala (Elder et 
al., 2012). Another study also induced increased acoustic startle, and enhanced contextual 
fear response 2-8 weeks following blast-exposure in mice (Heldt et al., 2014).  
Post-concussive symptoms
Emotional 
• Depression
• Anxiety
• Irritability
• Mood changes
Cognitive 
• Memory problems
• Concentration problems
• Decision making problems
Somatic
• Headache
• Fatigue
• Visual/hearing disturbances
• Dizziness
• Sleeping disturbances
• Nausea
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1.1.6 Neurochemical cascade following TBI 
 
Following  TBI there is an abrupt interference of cellular homeostasis, triggering a 
number of biochemical alterations in the brain. Some of these changes are summarised in 
Figure 1.4. Significant mechanical stress can cause shearing and stretch forces that in turn 
cause disruption to cellular membranes, known as mechanoporation, resulting in an efflux of 
K
+
 (Farkas et al., 2006). The efflux of K
+ 
causes neuronal depolarisation and firing, and 
indiscriminate release of neurotransmitters, mainly excitatory amino acids (EEAs) (Katayama 
et al., 1990). Thus there is a large increase in extracellular concentrations of glutamate 
(Katayama et al., 1990). EEAs can bind to a number of receptors and channels including n-
methyl-d-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) receptors (Faden et al., 1989). The engagement of these receptors and opening of 
more voltage gated channels (VGCs) result in further efflux of K
+
, and concurrently Ca
2+
 
starts to diffuse into the cell (Faden et al., 1989).  
 
At this point a number of cellular repair processes will be initiated, including 
activation of Na
+
-K
+
 pump to restore the ionic gradient (Giza and Hovda, 2001). This 
requires significant energy generation, thus a short period of hyperglycolysis ensues, lasting 
for some minutes to hours (Giza and Hovda, 2001). The increasing Ca
2+
 concentration is 
sequestered by the mitochondria, but the Ca
2+
 here inhibits oxidative metabolism (Choe et al., 
2012). Therefore, energy demands must be met by glycolysis, which in turn results in lactate 
accumulation and thus decreased ATP production (Giza and Hovda, 2001). Consequently, the 
cell enters a phase of metabolic suppression and widespread depression. Ca
2+
 is also 
implicated to be involved in enzyme activation and initiation of apoptotic pathways (Morgan 
and Curran, 1986). Immediate decreases in Mg
2+
 have also been found following a TBI; this 
has been shown to slow down recovery while, pre-treatment of animals with magnesium has 
resulted in improved post-traumatic neurological outcome (McIntosh et al., 1988; Vink et al., 
1987). Persistent emotional, cognitive, and somatic symptoms observed following a mTBI 
likely reflect disruptions in the neurochemical cascades described and their interaction with 
downstream effectors.  
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Figure 1.4 The neurochemical cascade initiated following a TBI.  
 
1.1.7 Repeated mTBIs 
Given the mild and mostly transient symptoms after mTBI/concussion and the 
absence of apparent structural changes, affected individuals often return to play or duty 
following a single mTBI and are at risk of repeated injury (Meehan and Bachur, 2009; 
Rosenfeld et al., 2013). A study looking at retired professional football players reveals 61% 
had suffered at least one concussion, and 24% had experienced 3 or more, while a soldier 
may be exposed to an average of 50 blast exposures during deployment (Guskiewicz et al., 
2005; Petrie et al., 2014). Little is known about the underlying mechanisms of injury, or the 
synergistic effect of repeated exposures, although suggestions have been made linking 
repeated mTBI with persistent symptomology and cognitive decline (Fehily and Fitzgerald, 
2016; Nichols et al., 2015). Repetitive blast exposures have been associated with 
hypometabolism in the cerebellum of veterans, delayed recovery, and/ or worsened 
symptomology of post-TBI sequelae (Carr et al., 2016; Hue et al., 2014; Nichols et al., 2016; 
Ojo et al., 2015).  
 
Concern have been raised about repeated head injuries possibly leading to latent 
pathological processes complicit in neurodegenerative disorders such as chronic traumatic 
encephalopathy (CTE) following repeated mTBIs (McKee and Robinson, 2014; Ojo et al., 
2015). Currently CTE is only diagnosable upon a neuropathological exam post-mortem, 
characterised by perivascular accumulation of tau protein in deep cortical sulci (McKee et al., 
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2015). Thus far, no definitive link has been made between blast exposure and CTE, but there 
are some limited case studies of service members with a likely CTE diagnosis, although it is 
uncertain if their injuries were purely blast-related or they had a history of other mTBIs 
(McKee and Robinson, 2014). While post-mortem studies of professional boxers and football 
players have revealed neurofibrillary tangles at sulcal depths and superficial cortical layers, 
with retrospective descriptions of early behaviour and mood changes, followed by later 
cognitive decline (McKee et al., 2013). Suggestions that repeated mTBIs may lead to 
increased vulnerability and decreased threshold for damage is an active area of research both 
clinically and pre-clinically.  
 
1.1.8 The role of sex-differences in TBI  
There is little consensus currently on the topic of TBI and sex-specific differences. 
Some studies implicate sex is a physiological factor, which can confer advantages or 
disadvantages to the injury cascade following TBI, while other findings do not support a sex-
specific difference. The biggest discrepancy appears to be between clinical and experimental 
data. In experimental TBI females appear more resilient, for example showing a delayed and 
lower magnitude of TBI associated neurodegeneration compared to males, including reduced 
oedema formation and blood brain barrier leakage, reduced inflammatory response and 
apoptotic cell death  (Günther et al., 2015; Kupina et al., 2003; O’Connor et al., 2006). The 
female hormones oestrogen and/or progesterone are implicated to play a role in the sex-
specific differences observed in animal models (Roof and Hall, 2000). The neuroprotective 
effects of progesterone has been demonstrated in several studies, where it has been shown to 
positively affect inflammation, oedema and plasticity following a TBI (Maghool et al., 2013; 
Si et al., 2014; Stein, 2013). While oestrogen has been shown to decrease anxiety-like 
behaviour (Hiroi et al., 2011).   
In clinical studies women appear more vulnerable to TBI both as a result of military-
related combat and in contact sports; they reportedly suffer more concussions and report more 
post-concussive symptomology (Bazarian et al., 2010; Brickell et al., 2017; Colvin et al., 
2009; Dick, 2009; Iverson et al., 2011). Some studies indicate that female veterans are more 
likely to have depression, or PTSD comorbid with depression, while male veterans are more 
likely to have PTSD with substance use disorder (Iverson et al., 2011; Pugh et al., 2016). 
While other studies do not find sex-specific differences in reporting of post-concussive 
symptoms, or believe it has only a limited influence in the military population (Jackson et al., 
2016; Rogers et al., 2014). Given the increasing number of females in military combat and 
participation in contact sports, concerns about women’s health following a mTBI have been 
raised and further research is warranted.  
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1.2 Monoaminergic and neuropeptidergic 
neurotransmission 
The underlying pathomechanisms of mTBI as a result of contact sports or exposure to 
explosive devices are poorly understood. Furthermore, the causal mechanisms which lead to 
persistent neuropsychiatric symptoms in some affected individuals are also relatively 
unknown. However, some aspects of the neurochemical changes immediately following 
injury have been delineated, including the indiscriminate release of neurotransmitters, mainly 
EEAs (as described before, see Figure 1.4). Other studies have also observed changes in other 
neurotransmitters including increased acetylcholine (ACh) and decreased NA levels in the 
seconds to hours post-TBI (Robinson et al., 1990; Saija et al., 1988; Tanaka et al., 1997). In 
fact, decreasing ACh with A-4 (a bis tertiary amine derivative of hemicholinium-3), 
significantly reduces behavioural deficits following TBI (Robinson et al., 1990), while 
administration of NDMA-antagonists (blocking the action of EEAs) also limited neurological 
dysfunction and had beneficial behavioural effects (Faden et al., 1989). Given these findings 
and the established role of some classical neurotransmitters in emotional and cognitive 
impairments, including symptoms that are characterised under PCS and PTSD, a role for 
neurotransmitter systems in the pathobiology of mTBI is likely. 
Furthermore, a role for neuropeptides and their receptors have also been considered 
relevant in relation to mood disorders (Hökfelt et al., 2003; Holmes et al., 2003; Nemeroff 
and Vale, 2005), and as a possible therapeutic and/or biomarker following TBI (Donkin et al., 
2011; Duan et al., 2013; Liu et al., 1994; Lorente et al., 2015). 
 
1.2.1 Noradrenaline and Serotonin 
A vast body of literature has firmly associated dysfunction in the classical 
neurotransmitter systems using noradrenaline (NA) or serotonin (5-hydroxytryptamine, 5-
HT) to stress/mood disorders (Mathew et al., 2008; Millan, 2006). Both systems have been 
implicated in the early hypotheses of depression, and are the targets of well-established 
pharmacological treatments of mood/anxiety disorders, such as major depression (Millan, 
2006) and PTSD (Davis et al., 1997; Krystal and Neumeister, 2009).  
Noradrenaline. NA is synthesised in the bilateral locus coeruleus (LC) nuclei, 
containing the noradrenergic cell group A6 in the brainstem (Dahlstrom and Fuxe, 1964), 
expressing the rate limiting enzyme tyrosine hydroxylase (TH; Figure 1.5a) (Nagatsu et al., 
1964). The LC innervates virtually all regions of the central nervous system (CNS), including 
the prefrontal cortex, both the dorsal and ventral hippocampal formation, and the 
hypothalamus (Ungerstedt, 1971). NA has been shown to play a key role in a number of 
processes including mood regulation, arousal, and as a stress hormone in the fight or flight 
response (Aston-Jones and Cohen, 2005; Berridge, 2008; Bremner et al., 1996; Goddard et 
al., 2010; Harro and Oreland, 2001). Upregulated NA levels are implicated in PTSD 
symptomology, associated with lack of sleep and increased nightmares of the traumatic event 
(Blanchard et al., 1991). 
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Serotonin. The raphe nuclei neurone cell groups, B1-B9, are the principal neurones 
that give rise to spinal and extensive serotonergic forebrain projections (Dahlstrom and Fuxe, 
1964; Steinbusch, 1981) and express the rate-limiting enzyme tryptophan hydroxylase 2 
(TPH2, Figure 1.5b) for 5-HT synthesis (Walther et al., 2003). 5-HT is involved in a vast 
array of physiological processes, including regulating sleep, appetite, pain and mood. Chronic 
stress has been shown to alter the level of 5-HT in the brain, specifically a reduction in the 
level of 5-HT is found in the plasma and CSF of some depressed patients (Gao et al., 2008). 
A reduction in 5-HT transporter binding has also been found in post-mortem brains of 
depressed patients (Maes, M and Meltzer, 1995).  
The levels of these monoamines and their metabolites have been examined in various 
animal models for TBI and models for a number of other stress/mood disorders. Increased 
levels of NA and DOPAC, concurrent with decreased 5-HT and HVA were found in the 
hippocampus of stressed animals (exposure to predator scent) in a PTSD model (Wilson et 
al., 2014). While halothane exposure, restraint and swim stress (consecutively) were reported 
to elevate NA, 5-HT and dopamine concentrations in the hippocampus after 7 days, but not 
after 1 h (Harvey et al., 2006). Furthermore, several studies have also reported elevations in 
the levels of the monoamine biosynthetic enzymes TH (Chang et al., 2000; Tóth et al., 2008; 
Yan et al., 2001) and TPH2 (Chamas et al., 1999, 2004; Donner et al., 2012; Shishkina et al., 
2007), respectively, following exposure to various types of stressors. 
 Significant increases in TH protein levels in the adrenal medulla and nucleus tractus 
solitarii of the brainstem, with associated elevated plasma NA levels at 6 h post-exposure to 
blast, have been reported (Tümer et al., 2013). Changes in monoamine turnover have also 
been reported in other TBI models, including decreased 5-HT and NA, and increases in the 
metabolite 5-HIAA ipsilaterally, six days after unilateral ventrolateral, cortical lesions 
(Finklestein et al., 1983). Pappius and Dadoun (1987) reported decreased 5-HT levels 
bilaterally after 1 d, and increased 5-HIAA, which remained elevated up to 10 d, following a 
unilateral, focal cortical freezing or heat lesion. The same group also demonstrated an 
increase in 5-HT synthesis in the cortex, hippocampus, and DRN using the same model 
(Tsuiki et al., 1995).  
There has been some success in the treatment of PTSD with pharmacological 
interventions. Treatment with an alpha-1 adrenergic antagonist, Prazosin, has shown efficacy 
for decreasing nightmares, sleep disturbances and other PTSD related symptoms in veterans 
(Raskind et al., 2003). Currently two FDA approved pharmacological drugs of PTSD are 
both selective serotonin reuptake inhibitors (SSRIs) (Davidson et al., 2001; Marshall et al., 
2001). Taken together, these studies suggest that the monoamine systems react in response to 
psychosocial stress and various types of TBI. However, thus far there have been no 
successful pharmacological interventions to improve post-TBI sequelae, despite attempts 
with several antidepressants. Lack of success has been explained by confounding factors, 
such as gender, timings of intervention post-injury, and heterogeneity of TBIs (Osier and 
Dixon, 2016).  
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1.2.2  Classical neurotransmitter and neuropeptide synthesis and 
release  
Classical neurotransmitters like the monoamines NA and 5-HT are synthesised in 
nerve cell bodies and nerve terminals from diet derived amino acids by several enzymatic 
steps (Figure 1.5). Commonly, they are then stored mainly in small synaptic vesicles, partly 
accumulated close to the active zone of the synapse, and released upon low frequency 
stimulations (Iversen et al., 2009). Classical neurotransmitters are recycled; there are reuptake 
mechanisms upon termination of their action (Iversen et al., 2009).   
Neuropeptides are formed in the cell body or dendrite of a neurone (Strand, 1999). 
Their synthesis takes place on ribosomes, and thereafter they are packaged into large dense 
core vesicles (LDCV) in the Golgi apparatus. The prepropeptide form is cleaved by specific 
enzymes to the bioactive form. LDCVs, sometimes also containing a classical 
neurotransmitter and one or more other neuropeptides, are transported from the cell body to 
the axonal terminal through fast axonal transport. Their release usually requires high 
frequency or burst firing for exocytosis, but both neuropeptides and neurotransmitters are 
Ca
2+
 dependant. Upon release they can bind to receptors on the cell soma, dendrites, axons 
and nerve endings, but have no reuptake mechanism and are inactivated by extracellular 
peptidases (Hökfelt et al., 2003; Lundberg, 1996).  
 
 
 
Figure 1.5 Biosynthesis of noradrenaline (a), and serotonin (b). 
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1.2.3 Galanin and galanin receptors  
Galanin is a 29 amino acid (30 in human) neuropeptide (Lang et al., 2015; 
Tatemoto et al., 1983). It is of considerable interest given its co-localisation with 
monoamines. In the rat it is co-expressed in around 80% of the noradrenergic neurones in 
the LC and in 40% of the serotonergic neurones in the DRN (Fuxe et al., 1998; Holets et 
al., 1988; Melander et al., 1986b). A potential therapeutic role for galanin following TBI 
has been suggested. Following a focal injury, using a fluid percussion model, rats treated 
with galanin prior to injury had significantly less motor deficits compared to their vehicle-
TBI injured counterparts (Liu et al., 1994). Galanin has also been implicated to play a role 
in mood/stress disorders (Juhasz et al., 2014; Karlsson and Holmes, 2006; Sciolino and 
Holmes, 2012; Weiss et al., 2005). It is believed to act as a neuromodulator inhibiting post-
synaptic neurotransmitter release, or exert a stimulatory effect on exocytosis (Lang et al., 
2015).  
Galanin signalling is hypothesised to be ‘silent’ under basal conditions and to 
be distinctly increased following stress exposure such as hyperactivity of the LC neurones. 
In support of this theory, upregulated levels of both TH and galanin have been reported 
following acute stress in the LC (Holmes et al., 1995; Kuteeva et al., 2010; Sweerts et al., 
1999). Furthermore, galanin inhibition of LC neuronal activity at the soma-dendrite level, 
may prevent generation of an overactive LC system (Pieribone et al., 1998; Vila-Porcile et 
al., 2009). This may lead to receptor supersensitivity and increased susceptibility to stress, 
possibly representing an early stage of depression (Harro and Oreland, 2001). Galanin also 
modulates 5-HT signalling (Fuxe et al., 1998), and inhibits 5-HT and NA release 
(Yoshitake et al., 2003). Galanin signalling has also been shown to modulate the stress 
response in an animal model of PTSD (Kozlovsky et al., 2009).  
Galanin mediates its actions through three G-protein coupled receptor subtypes, 
galanin receptor 1–3 (GalR1–3, Figure 1.6). These receptors are widely expressed across the 
peripheral nervous system (PNS) and CNS, in distinct and partly over-lapping regions 
(Waters and Krause, 2000). The receptors show high interspecies homology, but low 
homology to each other (Liu et al., 2010). 
  GalR1 is believed to inhibit release of neurotransmitters by acting through Gi/o 
type G-proteins, leading to reduced cyclic AMP (cAMP) concentrations, activating inwardly 
rectifying K
+ 
channels, and stimulating mitogen activating protein kinase (MAPK) activity 
(Branchek et al., 2000; Lang et al., 2015). GalR1 mRNA expression as determined by in situ 
hybridisation (ISH) was found in a number of forebrain regions including the hypothalamus, 
amygdala, ventral hippocampus and thalamus, and also in the brainstem including the LC 
(O’Donnell et al., 2003). In the hypothalamus GalR1levels are found increased in females 
compared to males and varies across the oestrus cycle (Faure-Virelizier et al., 1998). 
Upregulation of GalR1 in the vPAG has also been found in rats exposed to a chronic mild 
stress (CMS) model, and after knocking down GalR1with siRNA all parameters of the 
depressive-like phenotype were rescued (Wang et al., 2016).  
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GalR2 signals through both Gi/q and Gi/o type G-protein (Branchek et al., 2000; 
Lang et al., 2015). Activation through the Gi/q subunit triggers the phospholipase C (PLC) 
pathway, mobilises intracellular Ca
2+
, and has a stimulatory effect on exocytosis (Howard et 
al., 1997). While acting through the Gi/o subunit it has an inhibitory effect on exocytosis. 
GalR2 is widely distributed in the brain, including in the hypothalamus, hippocampus, 
amygdala and cerebellar cortex and also in peripheral tissues such as the heart, intestines, 
ovaries and prostate (O’Donnell et al., 2003; Waters and Krause, 2000). This receptor is 
thought to mediate ‘anti-depressive’ effects of galanin, given that it is decreased following 
CMS (Kuteeva et al., 2008; Lu et al., 2005). Also, stimulation by the GalR2 agonist M1896 
in the DRN has been shown to increase 5-HT release in the hippocampus (Mazarati et al., 
2005).  
Activation of GalR3, like GalR1 produces a hyperpolarising response by 
activating inwardly rectifying K
+
 channels consistent with coupling to Gi/o type G-protein 
(Branchek et al., 2000; Lang et al., 2015). GalR3 is also widely distributed in peripheral 
tissues such as the spleen, liver, heart and kidney, along with several brain regions including 
hypothalamus, cerebral cortex, caudate putamen, and medulla (Waters and Krause, 2000). 
Interestingly, GalR3 knockout mouse have been reported to exhibit an anxiety-like phenotype 
(Brunner et al., 2014).   
It should be noted that there are some species-specific differences with regards 
to galanin and its receptor distribution in the CNS. Particularly with respect to the brainstem, 
while GalR1 has been observed in many cells within the adjacent median raphe nucleus in the 
rat, in mice it is not detected (Larm et al., 2003). Furthermore, GalR1 and GalR2 are present 
in the LC and DRN in the rat, and GalR3 levels are very low, contrasting a distinct GalR3 
expression in the human LC (Barde et al., 2016; Le Maître et al., 2013).  
NA and 5-HT extensively innervate forebrain regions, play key roles in limbic 
circuits, and interact with other neurobiological mediators such as galanin. If these systems 
are dysregulated they likely cause deficits in attention, memory, arousal, sleep regulation, 
mood, and anxiety, leading to much of the symptomology described in PCS and PTSD in 
affected populations. This thesis will focus on these systems following a mild blast-induced 
TBI. 
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Figure 1.6 Schematic representation of the three galanin receptor subtypes (GalR1-3).  
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2 AIMS 
 
Aim 1: To study behavioural and neurochemical changes following a single 
blast exposure, focusing on the monoamine systems (Paper I). 
Aim 2: To study neurochemical changes following a single blast exposure, 
focusing on the galanin system (Paper II). 
Aim 3: To investigate the effects of multiple blast exposures on the monoamine 
and galanin systems in the brainstem (Paper III) 
Aim 4: To compare findings across two different rodent models of blast 
exposure in two different laboratories (Paper III).  
Aim 5: To explore the role of sex-specific differences on the monoamine 
systems following a single blast exposure (Paper IV).   
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3 METHODOLOGY 
3.1 Animals 
In all the studies included in this thesis were male or female Sprague Dawley rats 
(Taconic, Ry, Denmark) for experiments at Karolinska Institutet (KI, in Stockholm, 
Sweden), and (Charles River Laboratories, Wilmington, MA) for experiments carried out at 
the Uniformed Services University (USU, Bethesda, Maryland, USA). The weight ranged 
between 250-350 g. All work performed at KI were in accordance with the Swedish 
National Guidelines for Animal Experiments, and approved by the Stockholm Animal Care 
and Use Ethics Committee (Stockholm Norra Djurförsöksetiska Nämnd) with the following 
ethical permit numbers: N422/10, N248/11, and N81/13. The study carried out at USU was 
performed according to a protocol approved by the Institutional Animal Care and Use 
Committee at USU with the following ethical permit number: APG-14-911.  
The animals were deeply anaesthetised by using a 2.4 ml/kg intra-peritoneal 
injection consisting of a mixture of 1ml Dormicum® (5 mg/ml Midazolan; Roche), 1 ml 
Hypnorm® (Janssen) and 2 ml of distilled water (Studies I and II). Anaesthesia 
methodology was modified for study III and IV: here rats were anaesthetised using a 4% 
isoflurane-air mixture for 6 min (KI: Janssen, Stockholm, Sweden; USU: Forane, Baxter 
Healthcare Corporation, Deerfield, IL, USA). For the repeated exposure study animals were 
anaesthetised for 3 min approximately 30 min later. The animals were then exposed to the 
blast exposure.  
 
3.2 Exposure models 
3.2.1 Primary blast exposure model 
A validated 1.5 m long metal blast tube, designed by Clemedson in 1955 and since 
modified for studies on rodents, was used for the primary blast exposure (Clemedson et al., 
1956; Säljö et al., 2000). Swedish army plastic explosive containing explosive m/46, 86% 
pentaerythritol tetranitrate (PETN) and mineral oil was used with a NONEL ignition 
(Nobel, Sweden). Anaesthetised animals were placed in a rigid metallic holder that protects 
all parts of the body except the head. Furthermore, the holder prevented acceleration 
movements of the head relative to the rest of the body. The rats were mounted into the tube, 
in a transverse prone position and placed at a distance of 1 m from the charge. Five grams 
of the explosive was then detonated, triggering a simple blast Friedlander-type wave at the 
surface of the animal with a peak pressure of 550 kPa and a duration of 0.2 ms. The right 
side of the rat’s head faced the charge. Animals were housed on site, and all experimental 
manipulations, including the anaesthesia, exposure and sacrifice were carried out in the 
same laboratory (Study I-IV). This model is referred to as the ‘KI model’ (Figure 3.1).   
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Figure 3.1 A schematic presentation of the blast tube. 
 
3.2.2 Shock tube exposure model 
The shock tube is a 525 cm long, 30 cm in diameter, horizontally mounted, circular 
steel tube, and divided into a 75 cm compression chamber separated from a 450 cm 
expansion chamber by polyester Mylar sheets (Du Pont Co, Wilmington, DE, USA) 
(Elsayed, 1997; Long et al., 2009b). The peak pressure obtained varies depending upon the 
number and thickness of the Mylar sheets placed. The relationship between Mylar sheet 
thickness and the pressure produced is linear. Anaesthetised rats, wearing body protection, 
were placed in the shock tube holder in a transverse prone position, with the right side of 
the animal facing the incident blast overpressure. The average peak pressure was 88.9 kPa, 
with a 8-9 ms positive phase duration. Here, animals were transported from USU 
(Bethesda, MD, USA) to Walter Reed Army Institute of Research on the day of the 
exposures (WRAIR; Silver Spring, MD, USA) and transported back when the exposures 
were concluded (Study IV). We have referred to this shock tube as the “WRAIR model” 
(Figure 3.2). 
 
Figure 3.2 A schematic presentation of the shock tube. 
Reproduced with permission from (Elsayed, 1997).  
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3.3 Analysing gene and protein expression 
3.3.1 Immunohistochemistry 
Flouro Jade B (FJ) stains for degenerating neurones. Sections were air dried, fixed in 
4% formaldehyde, and rinsed in phosphate-buffered saline (PBS). The sections were 
subsequently dipped in dH2O, followed by 10 min incubation in potassium permanganate 
(KMnO4), and then rinsed with dH2O. Slides were then soaked for 30 min in FJ solution 
(Fluoro Jade B, Merk Millipore AG310, Darmstadt, Germany), washed in dH2O, and placed 
on a 50
o
C hot plate, dipped in xylene and thereafter mounted with Entellan (Merck, 
Darmstadt, Germany). 
 
White matter damage was evaluated by monitoring β-amyloid precursor protein 
(APP) accumulation. Sections were fixed in ice cold methanol, shortly dipped in ice cold 
acetone, then rinsed in PBS. Slides were then incubated in a humid chamber overnight with a 
solution of 0.3% Triton, 5% bovine serum albumin, and 0.1% sodium azide in 0.01M PBS 
and a rabbit poly-clonal antibody against APP (#51-2700, dilution 1:400; Life Technologies, 
Stockholm, Sweden). The following day all sections were rinsed in PBS and incubated for 1 
h with 0.01 M PBS, 0.1% sodium azide, 0.3% Triton, and processed with an Alexa Fluor 488 
conjugated anti-rabbit IgG (Jackson ImmunoResearch, dilution 1:400; Suffolk, UK). Sections 
were rinsed and mounted in a mixture of glycerol and PBS (1:3), then cover-slipped. Slides 
were viewed in a microscope equipped with epifluorescence (Eclipse E600, Nikon, Tokyo, 
Japan). 
Leakages of blood vessels were evaluated using a secondary rat antibody. Sections 
were processed as described for APP, including overnight incubation in a humid chamber, 
but not exposed to any primary antibody. The following day sections were rinsed in PBS and 
incubated with CY2-conjugated donkey anti-rat antibody (#712-225-153, dilution 1:100; 
Jackson ImmunoResearch, Suffolk, UK). Sections were then rinsed and processed as 
described for APP staining.   
 
3.3.2 In situ hybridisation (ISH) 
The rats were anesthetised and decapitated, the brains removed, placed on dry ice and 
stored at -70
o
C until use. Serial coronal, 14 µm thick sections at the level of the LC (bregma - 
10.52 – - 9.16 mm) and DRN ( - 8.30 – - 7.30 mm; coordinates according to Paxinos and 
Watson (Paxinos and Watson, 2007)) were cut using Cryo-Star HM 560 M (MICROM 
International GmbH, Heidelberg, Germany) and thaw mounted on super frost slide (Thermo 
Scientific, Stockholm, Sweden).  
Oligonucleotides complementary to rat mRNA for TH, TPH2, galanin, neuropeptide 
tyrosine (NPY) and aromatic acid decarboxylase (AADC) (Table 1) were labelled with 
deoxyadenosine 5’triphosphate α–P32 (Perkin Elmer, Boston, MA) at the 3′-end using 
terminal deoxynucleotidyltransferase (Thermo Scientific, Waltham, MA). The labelled 
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oligoprobes were purified using ProbeQuant G-50 Micro Columns (Amersham Pharmacia 
Biotech, Piscataway, NJ). Sections were air-dried and incubated with the oligonucleotide 
probe for 18 h at 42
o
C (Dagerlind et al., 1992).  
RNA probes specific to GalR1 were prepared from rat hypothalamus cDNA (Table 
1). The PCR fragments were then subcloned into PCR1II-TOPO vector (Life Technologies, 
Carlsbad, CA) and transcribed using T7 and SP6 RNA polymerases to generate sense and 
antisense RNA probes.  
For the Ribo-ISH the sectioned tissues were first fixed for 10 min in cold 4% 
paraformaldehyde in 0.1 M sodium phosphate buffer (PBS), pH 7.4, followed by 5 min in 1 x 
PBS, DEPC-treated water, and 0.1 M HCl, 3 min in PBS (twice), 20 min in 0.25% acetic 
anhydride in 0.1 M triethanolamine, 3 min in PBS (twice), and then dehydrated for 2 min in 
ascending ethanol concentrations and stored at -20°C until pre-hybridisation. Sections were 
prehybridised using 50% deionized formamide (pH 5), 50 mM Tris-HCl (pH 7.6), 25 mM 
ethylene-diamine-tetraacetate (EDTA, pH 8), 20 mM NaCl, 0.25 mg/ml yeast tRNA, 2.5 x 
Denhardt’s solution for 4 - 6 h at 55ºC, and subsequently hybridised in a humidified chamber 
overnight (16 h) at 55ºC.  
Labelled probes were diluted to a concentration of 1.0 x 10
6 
c.p.m./200 µl in a 
solution containing 50% deionized formamide (pH 5), 0.3 M NaCl, 20 mM dithiothreitol, 0.5 
mg/ml yeast tRNA, 0.1 mg/ml poly-A-RNA, 10% dextran sulphate and 1 x Denhardt’s 
solution. Following hybridisation, sections were washed with constant stirring as follows: 30 
min in 1 x SSC at 55°C (twice), 1 h in 50% formamide/0.5 x SSC at 55°C, 15 min in 1 x SSC 
at 55°C, 1 h in RNase A buffer at 37°C, 15 min in 1 x SSC at 55°C (twice), dehydrated in 
ascending alcohol series (2 min each) and finally air dried. 
Post-hybridisation, all sections were rinsed in 1 x SSC, 5 x 30 min at 55
o
C followed 
by 1 h at room temperature (RT), dehydrated with ascending ethanol concentrations, air-dried 
and dipped in liquid photo emulsion NTB2 at RT(Kodak, Rochester, NY). 
The optimal exposure time was determined by exposing the slides to imaging plates 
(BAS-SR Fujifilm, Tokyo, Japan) for 24 h at RT, which were scanned using a 
phosphoimager (Fuji BAS 3000, Tokyo, Japan). Based on this data, TPH2 slides were 
developed after 72 h, galanin and TH typically after one week, and GalR1 after 8-12 weeks 
using D19 developer (Kodak) and AL-4 fixative (Kodak) and mounted in glycerolphosphate 
buffer.  
Dark field photomicrographs were captured using a microscope (Nikon Eclipse E-
600; Nikon, Tokyo, Japan), connected to a digital camera (Digital Sight, U1; Nikon). The 
images were analysed according to the mean grey density (MGD) of the messenger 
ribonucleic acid (mRNA) signal in the regions of interest (ROIs), using ImageJ 1.48 
(National Institutes of Health, Bethesda, MD). 
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Table 3.1. Probes used for ISH and qPCR.  
 
3.3.3 Quantitative polymerase chain reaction (qPCR) 
The following regions were dissected using anatomical landmarks (Paxinos and 
Watson, 2007): prefrontal cortex (PFC), occipital cortex (CX), entorhinal cortex (ERC), 
hypothalamus (Hyp), amygdala (Amg), dorsal and ventral hippocampal formation (dHiFo 
and vHiFo). Both ipsi (left)- and contra (right)-lateral regions were dissected, except for 
Hyp (Figure 3.3 a-d). Tissue blocks including LC and vPAG/DRN were removed using 
tissue punches (AgnTho's AB, Lidingö, Sweden, Figure 3.3 e-f). 
Total RNA was extracted using RNeasy plus mini kit (Qiagen, Düsseldorf, Germany) 
for the dissected regions and using RNAqueous micro kit (Life Technologies) for the tissue 
punches. After reverse-transcription using iScript select cDNA synthesis kit (Bio-Rad, 
Berkley, CA), qPCR was performed using the SYBR green PCR master mix and ABI 
Prism® 7000 sequence detection system (Life Technologies) under the following conditions: 
50°C for 2 min, 95°C for 10 mins, followed by 45 consecutive cycles of 95°C for 15 sec and 
60°C for 1 min. Relative gene expression was determined by the 2
−ΔΔ
CT method and 
normalised to the housekeeping gene GAPDH (primer sequences used are shown in Table 1). 
 
Probe
Gene Bank 
accession no.
Primers 
TH NM_012740 GCG CTG GAT ACG AGA GGC ATA GTT CCT GAG CTT GTC
TPH2 NM_017139 TCC TCC GTC CAA ATG TTG TCA GGT GGA TTC AGC GTC ACA ATG GTG GTC
GGTGCACAGTGGGTGTGGTCTCAGGACTGCTCT
ATGCCAGGCAGGCTGTCGAGGGCCCCGGCCTCT
GTGCGGACGATATTGCTCTCAGGCAGGGGTACA
CCCGAGCCCCAGAGTGGCTGACAGGGTTGCAACCAACAGGAGCCAGGC
TTGTCAATGGCATGTGGGCCCAGAAGGTAGCCA
NPY NM_012614 TTGATGTAGTGTCGCAGAGCGGAGTAGTATCTGGCCATGTCC
AADC NM_012614 TACCAGCTGATATATCGGCTGATAGACCTGCCGTATCTCCC
TTTGTGGACTGGCACCTCCTTCCGA (Fwd)
TTTCCTGGGTTCTTTGGAGGCCCA (Rev)
TGCAACCCTGTCAGCCACTC (Fwd)
TGTCGCTAAATGATCTGTGGTTGTC (Rev)
AGGCTTACGTGGTGTGCACTTTC (Fwd)
GCCATGATATGCCAAATACCACAA (Rev)
CATCGTGGCGGTGCTTTT (Fwd)
AGCGGGAAGCGACCAAAC (Rev)
AGGAAGATGAGGGCAAAG (Fwd)
GAAGATGACATGAAACCAGG (Rev)
GGCACAGTCAAGGCTGAGAATG (Fwd)
ATGGTGGTGAAGACGCCAGTA (Rev)
Primers used for oligo in situ hybridization
Galanin NM_017139
Primers used to synthesize riboprobes
Rat GalR1 NM_012958
Primers used for qPCR
Rat Galanin NM_017139
Rat GalR1 NM_012958
Rat GalR2 NM_019172
Rat GalR3 NM_019173
Rat GAPDH NM_017008
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3.3.4  Radioimmunoassay 
Both ipsi- and contralateral sides of the following regions were rapidly dissected: 
PFC, Amg, dHiFo, and vHiFo. The LC and vPAG were punched out as described with qPCR 
(Figure. 3.3). The tissue samples were weighed, extracted in acetic acid, boiled, 
homogenised, centrifuged, lyophilised and dissolved before analysis, as previously described 
(Theodorsson and Rugarn, 2000). Rat galanin-like immunoreactivity was analysed using 
antiserum RatGala4 raised against conjugated synthetic rat galanin, measuring a single 
immunoreactive component corresponding to rat galanin (1-29) (HPLC), but also included 
immunoreactive molecules eluting right after the void volume (gel-filtration chromatograms) 
(Theodorsson and Rugarn, 2000). Competitive RIA of cholecystokinin (CCK) was performed 
as described for galanin using antiserum Ab 2609 (Rehfeld, 1987). 
 
 
3.4 Neurochemical analyses  
3.4.1 High-performance liquid chromatography (HPLC) 
Chemicals required for HPLC included: NA hydrochloride, DA hydrochloride, 5-HT 
hydrochloride, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-
hydroxyindoleacetic acid (5-HIAA), potassium chloride, phosphate monobasic monohydrate, 
sodium phosphate dibasic, sodium acetate, citric acid, octanesulfonic acid sodium salt and 
methanol, which were obtained from Sigma-Aldrich (St. Louis, MO, USA). EDTA-2Na was 
purchased from Dojindo (Kumamoto, Japan).  
The following regions were dissected using the appropriate landmarks as described 
before: PFC, Hyp, dHiFo, vHiFo, CX and ERC (Figure 3.3 a-d). Both ipsi (left)- and contra 
(right)-lateral regions were isolated (except for the Hyp), put into marked plastic vials, and 
placed on dry ice. 
Dissected brain tissue samples (1-10 mg) were mixed at a ratio of 1:10 (w/v) with 0.2 
M perchloric acid including 100 µM EDTA-2Na, and homogenised in a glass-pestle micro-
homogeniser. Following standing for 3 min on ice, the homogenates were centrifuged for 15 
min at 12,000 g at 4C. The supernatants were aspirated and mixed with 1 M Na-acetate 
buffer, pH 3 at a ratio 5:1 (v/v) and filtered through a 0.22 µm centrifugal filter for 4 min at 
12,000 g at 4C. The filtrates were stored at -80C before HPLC analysis. 
Concentrations of  NA, DA, and 5-HT in the brain tissue samples were determined by 
HPLC with electrochemical detection as described by (Kehr and Yoshitake, 2006). The 
HPLC system consisted of a HTEC500 unit (Eicom, Kyoto, Japan), and a CMA/200 
Refrigerated Microsampler (CMA Microdialysis, Stockholm, Sweden) equipped with a 20 μl 
loop and operating at 4°C. The potential of the glassy carbon working electrode was +450 
mV versus the Ag/AgCl reference electrode. The separation was achieved on a 200 x 2.0 mm 
Eicompak CAX column (Eicom). The mobile phase was a mixture of methanol and 0.1 M 
phosphate buffer (pH 6.0) (30:70, v/v), containing 40 mM potassium chloride and 0.13 mM 
EDTA-2Na. The chromatograms were recorded and integrated by use of a computerised data 
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acquisition system Clarity (DataApex, Prague, Czech Republic). The detection limit (signal-
to-noise ratio = 3) for NA, DA and 5-HT was 0.05 nM, that is, 0.75 fmol in 15 μl injected 
onto the column respectively. 
Concentrations of DOPAC, HVA, and 5-HIAA were determined by a separate HPLC 
system with electrochemical detection (HTEC500). The potential of the glassy carbon 
working electrode was +750 mV versus the Ag/AgCl reference electrode. The separation was 
achieved on a 150 x 3.0 mm Eicompak SC-5ODS column (Eicom). The mobile phase was a 
mixture of methanol and 0.1 M citrate/0.1 M sodium acetate buffer solution (pH 3.5) (16:84, 
v/v) and contained 210 mg/l octanesulphonic acid sodium salt and 5 mg/l EDTA-2Na. The 
detection limit (signal-to-noise ratio = 3) for DOPAC, HVA and 5-HIAA was 2 nM, that is, 
10 fmol in 5 μl injected onto the column. The chromatograms were recorded and integrated 
by use of the computerised data acquisition system Clarity (DataApex). 
 
 
Figure 3.3 Schematic presentation of brain regions dissected for qPCR, RIA, and HPLC analysis (a-f). Images 
repreinted with permission from The Paxinos and Watson atlas (Paxinos and Watson, 2007).   
 26 
3.5 Serum analyses  
3.5.1 Enzyme-linked immunosorbent assay (ELISA) 
All assays were run in accordance to manufacturer’s instructions. Progesterone 
(PROG) and estradiol (E2) levels were measured using Rat PROG ELISA Kit and Rat E2 
ELISA Kit (both from CUSABIO, Nordic BioSite, Stockholm, Sweden).  
Substance P (SP) levels were measured using Biomatik ELISA Kit (Biomatik 
Corporation, Ontario, Canada). Each sample was diluted 1:2.  
Corticosterone (CORT) levels were measured using abcam’s Corticosterone ELISA 
Kit (BioNordika, Stockholm, Sweden), here samples were diluted to 1:100.  
S100 levels were determined using CanAG S100 assay (CanAg Diagnostics AB, 
Gothenburg, Sweden).  
The levels of mature BDNF were analysed with Biosensis RapidTM Mature BDNF 
ELISA Kit (VWR, Stockholm, Sweden). Samples were diluted 1:100.  
 
3.6 Behavioural tests 
3.6.1 Forced Swim Test- FST  
Anxiety-/depression-like behaviour was measured using the FST (Porsolt et al., 1978) 
at 1 d pre-exposure (baseline) and 1 d, 14 d, and 35 d post-exposure. Animals were 
individually placed in a vertical plastic cylinder (50 cm height, 18 cm diameter) containing 
water to a height of 30 cm, at a temperature of 25 ± 0.5
o
C. Animals were exposed to two 
swimming sessions, twenty-four hours apart: a 10-min pre-test, and a 5-min test. The total 
duration of immobility and climbing behaviour were recorded during the second test day. 
Immobility was defined as floating passively in an upright position in water, with only small 
movements necessary to keep the head above the water surface, typically only one paw 
movement at a time (Detke et al., 1995). Climbing was defined as vigorous fore-paw 
movements directed toward the walls of the cylinder (Figure 3.4).  
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Figure 3.4 The forced swim test. The different behaviours that can be measured are illustrated (a) climbing and 
(b) immobility behaviour.  
 
 
3.7 Statistical analysis  
GraphPad Prism version 5 or 6 (GraphPad Software, CA) was used to perform 
all statistical analyses using ANOVA followed up by Tukey-Kramer Multiple Comparison 
Test and independent t-tests. All data are presented as the mean ± SEM, where statistically 
significant data is highlighted: * p <0.05, ** p <0.01, *** p <0.001 **** p <0.0001. 
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4 RESULTS AND DISCUSSION 
 
4.1 Paper I: The monoamine systems and mbTBI 
The underlying pathomechanisms of a blast-induced mTBI are still relatively 
unknown. Exposure to blast appears to cause persistent and lingering neuropsychiatric 
symptoms including mood disorders and anxiety in a subset of those injured. Monoamine 
projections from the brainstem and midbrain, particularly noradrenaline in the locus 
coeruleus and serotonin in the dorsal raphe, play a key role in modulating the functions of 
forebrain regions. Dysfunctions in these systems have been associated with mood/anxiety 
disorders implicating these regions and neurotransmitters in the pathomechanism of 
neurobehavioral symptoms after blast-induced mTBI. In this study we sought to identify 
behavioural and neurochemical changes in the monoamine systems following a blast-induced 
mTBI.    
We first examined sections from both the brainstem and forebrain regions for 
degenerating neurones, blood vessel leakage and APP accumulation to ascertain, if our model 
did indeed produce a mild TBI. Lack of neuropathological findings with this series of staining 
indicates it is indeed, in line with other studies of mbTBI (Elder et al., 2012; Kamnaksh et al., 
2012; Kwon et al., 2011).  
 
We then explored changes in the transcript levels of the monoamine 
synthesising enzymes in the brainstem, and the levels of the neurotransmitters NA, DA, and 
5-HT, along with their metabolites DOPAC, HVA, and 5-HIAA, in a number of forebrain 
regions. We found an acute and transient increase in TH transcript levels bilaterally in the 
LC, and of TPH2 in the mid/caudal, but not rostral, DRN as early as 2 h post-exposure. The 
levels of TH and TPH2 returned to sham levels at 7 and 3 d, respectively. With regard to the 
neurotransmitter levels and those of the metabolites, the most striking changes were confined 
to the NA system. We measured significant increases in NA levels 1 d post-exposure in a 
number of forebrain regions (i.e., projection areas of the LC-NA neurones, Table 1A). DA 
was also increased, but elevations were limited to the hippocampus. No changes were 
observed in 5-HT levels, but its metabolite 5-HIAA was decreased in the PFC. All these 
changes occurred acutely, that is at 1 d post-exposure. At 7 d, two metabolites of the 
catecholamine system, DOPAC and HVA, were decreased in the cortex and hippocampus 
(Table 1B).  
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The increase in monoamine levels suggests a significant release of 
neurotransmitters, which is followed by compensatory re-synthesis. This would also account 
for the elevation seen in transcript levels of the monoamine synthesising enzymes and the 
decrease in metabolite levels. 
 
Many neurones release chemical messengers following stress exposure, 
including excitatory amino acids such as glutamate, as well as acetylcholine, NA, DA, and 5-
HT, in some cases more than one. Monoamine turnover has previously been examined in a 
number of studies looking at TBI, PTSD, and other trauma and stress-related models, and the 
studies report selective and specific changes in these systems (Faden et al., 1989; Pappius and 
Dadoun, 1987; Tanaka et al., 1997; Tsuiki et al., 1995; Wilson et al., 2014).  
 
Taken together our findings are in line with the literature, where the LC-NA 
system appears to be distinctly sensitive to stress (Bremner et al., 1996; George et al., 2013; 
Korf et al., 1973; Usher, 1999). Furthermore, increased TH and TPH2 transcript levels in 
response to various stressors have also been extensively reported on (Chamas et al., 1999, 
2004; Rusnák et al., 1998; Yan et al., 2001).  
 
We also evaluated functional changes in anxiety-/depression-like behaviour 
with the FST, during a 5-min test session ran at 1 d pre-exposure (baseline) and 1 d, 14 d, and 
35 d post-exposure (Figure 4.1). As expected, no behavioural differences were found pre-
exposure across the groups: control, sham, and exposed. However, 1d post-exposure the 
exposed group exhibited decreased immobility relative to the control and sham groups 
(Figure 4.1a). The values for the climbing behaviour were also highest in the exposed group, 
but this was not statistically significant (Figure 4.1b). Similar climbing and immobility 
behaviours were observed across the groups for remaining test sessions.  
 
FST has been used to assess learned helplessness following a TBI in several 
studies with mixed findings, some have reported no changes (Jones et al., 2008), and others 
have seen increased immobility (Milman et al., 2005). Here, we have interpreted the reduced 
immobility behaviour immediately following exposure as hyperarousal, based on previous 
observations that the most anxious animals as evaluated by the elevated plus maze, would 
spend the least time immobile in the FST (Estanislau et al., 2011). Furthermore, treatment 
with antidepressants that increase the availability of NA reduces immobility behaviour by 
increasing time spent climbing (Detke et al., 1995; Detke and Lucki, 1996). Hence it is likely 
that the widespread elevation in NA levels we observed in the forebrain regions is responsible 
for the significant reduction in immobility behaviour.  
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Figure 4.1 Time of immobility (a) and climbing (B) behaviour in the forced swim test measured at 1 d pre-
exposure (baseline), and 1 d, 14 d, and 35 d post-exposure.  
* p < 0.05. 
 
4.2 Paper II: The galanin system and mbTBI 
Co-existence of more than one neurotransmitter in neurones has now been well 
established (Agoston and Conlon, 1986; Hökfelt et al., 2003, 1986; Nemeroff and Vale, 
2005). The neuropeptide galanin is co-localised with both NA and 5-HT in the brainstem and 
midbrain, and similarly innervates the forebrain regions (Fuxe et al., 1990; Melander et al., 
1986a; Xu and Hökfelt, 1997). Galanin has been implicated to play a role in mood/stress 
disorders, and is believed to act as a neuromodulator modulating neurotransmitter release 
and/or by acting on postsynaptic sites by signalling through its receptors, galanin GalR1-3 
(Branchek et al., 2000; Habert-Ortoli et al., 1994; Lang et al., 2015). In this study we 
examined changes in galanin and its receptors following a single blast exposure.  
 
The levels of transcripts for galanin and those of its three receptors, also of the 
galanin peptide itself, were perturbed in the brainstem and forebrain regions following a 
single blast exposure. A significant upregulation of galanin transcripts were observed as early 
as 2 h and 1 d post-exposure in the LC and DRN, respectively, and remained elevated until 
D7, the furthest time-point changes were evaluated. Hence changes in the galanin system in 
the LC and DRN appeared to be more persistent than TH and TPH2, respectively (Figure 
4.2). While in the forebrain, a robust and significant increase in galanin mRNA level was 
observed at D1 in the dHiFo and vHiFo based on the qPCR analysis. We attempted to 
visualise this with riboprobe in situ hybridisation and autoradiography, but unfortunately 
even after eight weeks of exposure of the hybridised slides we could not detect a signal.   
 
Accumulating evidence suggests neuropeptides are of particular importance 
when the nervous system is challenged e.g. by stress or traumatic events, serving to modulate 
the activity of the co-expressed neurotransmitters (Hökfelt, 1991; Lundberg and Hökfelt, 
1986). Hence, the differential regulation of galanin and the monoamine synthesising enzymes 
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observed in this study are in line with previous observations. Galanin signalling is 
hypothesised to be ‘silent’ under basal conditions and primarily increased, when the LC 
neurones are hyperactive. Consistent with this theory, galanin applied directly on to the LC 
neurones caused hyperpolarisation, presumably by increased K
+
 conductance mediated by 
activation of GalR1/3 receptors (together with noradrenergic inhibition via alpha2A 
receptors) at the soma-dendrite level (Pieribone et al., 1998; Seutin et al., 1989; Sevcik et al., 
1993; Vila-Porcile et al., 2009). Furthermore, microdialysis sampling of the ventral 
hippocampus following galanin infusion revealed a long lasting and dose dependant 
reduction in 5-HT levels in the rat (Kehr et al., 2002).  
 
 
 
Figure 4.2  Correlation of changes in transcripts for galanin (Paper II)) and for TH and TPH2 (Paper I) in the LC 
(a) and DRN/vPAG (b, c). Both in the LC and mid/caudal DRN galanin mRNA levels remain elevated at D7. 
 
The wide distribution of galanin receptors (O’Donnell et al., 2003), mediating 
both inhibitory and stimulatory effects (Lang et al., 2015) contributes to the complex changes 
in the activity of the neurones expressing these receptors and likely explains some 
inconsistent findings regarding galanin function in mood/ anxiety disorders. Analysis of the 
receptor transcripts with ISH in this study revealed several significant changes, in particular a 
persistent upregulation in GalR1 levels in the mid/caudal vPAG which coincided with a 
significant decrease in GalR2 in the same region at 7 d post-exposure. In the forebrain, 
changes were predominately confined to GalR3, which in general decreased acutely, but this 
decrease was maintained in the vHiFo even after 7 d post-exposure. Also GalR2 was 
significantly increased in the vHiFo and Amg at 1 d post-exposure. 
 
These differential changes in the receptors in the different brain regions are 
intriguing given the differential functions of the receptors. GalR1/3 primarily mediates 
inhibitory actions in the brain, while GalR2 can have both stimulatory and inhibitory effects. 
In fact stimulation of GalR2 in the DRN by the agonist 1896 has been shown to increase 5-
HT release in the hippocampus (Mazarati et al., 2005). Moreover, elevated GalR1 levels in 
the vPAG, have also been observed in rats exposed to chronic mild stress, which lead to the 
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onset of depressive-like behaviour (Wang et al., 2016) . This phenotype could be rescued by 
knocking down expression of this receptor. This is further underscored by recent findings 
showing increased GalR1 levels (measured by qPCR) in the DRN/vPAG in human depressed 
suicides versus controls (Barde et al., 2016). These results lend further weight to the present 
findings observed in the mbTBI. Thus the persistent increased and decreased transcripts of 
GalR1 and 2, respectively, in the DRN/vPAG suggest that this brain region may be key area 
for mood control. 
 
The galanin peptide levels in the punched sample containing LC were increased 
at 3 d, returning to sham levels on 7 d post-exposure. A likely interpretation of this increase is 
that initially synthesis is increased to compensate for release of the peptide, and that the 
elevation is a result of accumulation of newly synthesised peptide that will be transported. At 
this time-point, galanin peptide levels were significantly decreased in the vPAG sample. In 
the forebrain, galanin peptide levels were significantly increased in the dHiFo, and Amg at 3 
d. By 7 d significant galanin decreases versus sham levels were measured in the PFC, vHiFo, 
and Amg.  
 
We also looked at the transcript levels of neuropeptide Y in the LC, and CCK 
peptide levels in the brainstem and forebrain regions. Changes were limited to only a 
significant increase in CCK peptide levels in the LC sample both at 3 and 7 d after blast, 
suggesting despite the general similarities in these peptide systems, they are differentially 
regulated and presumably have different functions. The CCK in the LC area is known to be 
confined to nerve endings (Sutin and Jacobowitz, 1988). Whether the increased levels 
represent increased or decreased release remains to be explored, but it was early shown that 
CCK is an excitatory peptide (Dodd and Kelly, 1981).  
 
 
4.3 Paper III: The monoamine and galanin system following repeated 
mbTBI 
 Due to the subtle nature or lack of clinical symptoms following mTBI and the 
absence of readily available, objective diagnostic tools, individuals who have suffered mTBI 
typically return to duty or play, where they are at risk of repetitive injuries (Meehan and 
Bachur, 2009; Petrie et al., 2014). Little is known about the adverse effects of repetitive 
mTBIs, but it has been suggested that there is a period of increased cerebral vulnerability 
(ICV) following the injury. ICV is currently interpreted that the brain may not have 
completely recovered from the initial injury and further insults would have cumulative effects 
(Vagnozzi et al., 2008; Weil et al., 2014). Hence this study was prompted based on two 
motivations, first to examine the effects of multiple exposures on the monoamine and galanin 
systems. Second, to explore how these findings would vary across two commonly used 
models of blast-induced mTBI.  
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One day following exposure, sections from the forebrain were evaluated for 
degenerating neurones using FJ-B histology, and for axonal damage by staining for APP 
accumulation. No positive staining, hence no evidence of cell degeneration, or signs of 
axonal injury were detected in rats following either of the single or repeated exposure in 
either model. This is consistent with previous findings that, while exposure to mild blast 
results in functional changes as evident in behavioural deficits in both models, there do not 
appear to be structural changes (Ahmed et al., 2013; Kawa et al., 2014; Kwon et al., 2011). 
This could be due to the difference in outcome measures because for example Budde and 
colleagues have found gross changes in the hippocampus when using diffusion tensor 
imaging (DTI), which they related to significant deficits in memory function in the Morris 
Water Maze (Budde et al., 2013). Moreover, Kamnaksh et al., (2014) found acute subcortical 
changes after mbTBI also when using DTI. 
 
Post-concussive symptoms following mbTBI and the possibility that symptoms 
may be compounded by repeated exposures have been extensively reported on in the 
literature (Kennedy et al., 2010; Marion et al., 2011; Mendez et al., 2013; Carr et al., 2016). 
Based on our previous findings in Paper I and II, we wanted to examine how the NA, 5-HT, 
and galanin systems were affected by repeated exposures. Importantly we wanted to examine 
if these changes could also be replicated in other blast-models, as this could greatly influence 
the translatability of these findings.  
 
We observed increased transcript levels of TH and TPH2 in the LC and DRN, 
respectively, and galanin in both regions, consistent with our previous findings in the KI 
model following a single exposure (Figure 4.3 and 4.4). But we did not find cumulative 
effects of repeated exposures in either region in the transcript levels of these molecules, in 
either of the two rodent models used. Furthermore, changes in TH and galanin in the LC were 
only statistically significant in the KI model, not in the WRAIR model, here only a trend 
towards an increase was observed (Figure 1). While in the mid/caudal, but not rostral DRN, 
an increase in the transcript levels of TPH2 and galanin were also observed at 1 d post-
exposure. Again, this increase was statistically significant in the KI model for both the single 
and double exposed groups. While in the WRAIR model, a trend was seen towards an 
increase in the single exposed vs sham group, but this only became statistically significant 
after the second exposure to blast over pressure (Figure 4.4). 
 
These observations lend more support to the NA, 5-HT, and galanin systems 
playing a likely role in the pathobiology of mbTBI and associated persistent neuropsychiatric 
complaints. The partially consistent findings across the two models are promising, suggesting 
these changes are not unique to the KI model but likely a feature of blast exposure. With 
cautious optimism, this has significant translatability implications given that in the TBI field 
we struggle with being able to replicate findings across models and eventually translate the 
findings to the clinic.  
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The discrepancies in the findings may be explained by the characteristics of the 
blast models. In the KI model the blast wave has a high peak pressure and short duration, and 
also the rodents here are exposed to some of the smoke and heat generated by the detonation. 
While in the WRAIR model the blast over pressure has lower peak but a longer duration, and 
furthermore animals are transported to and from the facility, thus there is an additional stress 
component along with the blast.  
 
Our findings are consistent with numerous studies that have demonstrated 
changes in the NA, 5-HT, and galanin systems in response to various stressors (Chamas et al., 
1999, 2004; George et al., 2013; Sweerts et al., 1999; Tóth et al., 2008; Weiss et al., 2007). 
The lack of cumulative effects following repeated exposure observed in this study could 
indicate these systems become habituated to the repeated stressor, as shown in previous 
studies, where TH transcript levels were significantly lower after prolonged immobilisation 
stress, despite initially increasing, indicating a possible adaptation of the system (Rusnák et 
al., 1998). Similar observations were made with preprogalanin mRNA, which was initially 
decreased in the LC, but returned to control levels as restraint sessions increased (Sweerts et 
al., 1999).   
Moreover, perhaps these findings should not be taken to mean that there are no 
cumulative effects across the system as we have only looked at transcript levels here, but how 
faithfully these are translated to proteins and to functional changes remain to be evaluated. In 
fact, Kvetnansky and Sabban (1998) found an increase in TH transcript levels within hours in 
their stress model, but a marked increase in adrenal TH activity was only evident after seven 
days. We have only analysed changes after 1 d, perhaps extending to a longer period of time 
would reveal more.  
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Figure 4.3 ISH analysis of transcript levels of TH and galanin in the LC following exposure to single or 
double mbTBI, using two different models of TBI, in two different laboratories. (a,j) Quantification of 
transcript levels of TH (a) and galanin (j) revealed that both were significantly increased bilaterally at 1 day 
post-exposure in the single and double exposed groups, relative to their respective shams using the KI model. 
While the same trend was seen in exposed groups vs shams in the WRAIR model, the elevations were not 
statistically significant in any of the transcripts. There did not appear to be a cumulative effect of repeated 
exposure in either model.  
(b-i, k-r) Representative dark field ISH photomicrographs of emulsion-dipped sections show the distribution 
and levels of TH (b-i) and galanin (k-r) transcripts levels. TH mRNA levels in the single (b), and double (c) 
exposed groups in the LC, relative to sham single (d), and double (e) groups using the KI model. (f-i) show 
TH mRNA distribution and levels in the single (f), and double (g) exposed groups using the WRAIR mbTBI 
model, and their respective sham groups; single (h), and double (i).Photomicrographs (k-r) show galanin 
transcript levels: the single (k) and double (l) exposed groups using the KI model, and their respective shams, 
single (m) and double (n); the single (o), and double exposed (p), and single (q), and double (r) sham groups, 
using the WRAIR model.  
Data are presented as mean ± SEM. (* p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).  
ISH, in situ hybridisation; LC, locus coeruleus; TH, tyrosine hydroxylase. 
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Figure 4.4 ISH analysis of transcript levels of TPH2 and galanin in the mid/caudal DRN following 
exposure to single or double mbTBI, using two different models of TBI, in two different laboratories. 
(a,j) Quantification of transcript levels of TPH2 (a) and galanin (j) mRNA levels showed a significant 
increase at 1 day post-exposure in the single and double exposed groups relative to their respective shams 
using the KI model. While the same trend of an elevation was also observed in exposed groups vs shams 
using the WRAIR model, this was only statistically significant in the double exposure group. There did not 
appear to be a cumulative effect of repeated exposure in either model.  
(b-i, k-r) Representative dark field ISH photomicrographs of emulsion-dipped sections show distribution and 
levels of TPH2 (b-i) and galanin (k-r) transcripts. TPH2 mRNA levels in the single (b), and double (c) 
exposed groups, relative to sham single (d), and double (e) groups using the KI model. (f-i) show single (f), 
and double (g) exposed groups using the WRAIR model, and their respective single (h), and double (i) sham 
groups. Photomicrographs (k-r) show galanin transcript levels: the single (k) and double (l) exposed groups 
using the KI model, and their respective shams, single (m) and double (n); the single (o), and double exposed 
(p), and single (q), and double (r) sham groups, using the WRAIR model.  
Data are presented as mean ± SEM. (* p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).  
ISH; in situ hybridisation, DRN; dorsal raphe nucleus, TPH2; tryptophan hydroxylase 2. 
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4.4 Paper IV: Sex-specific differences in the monoamine systems following 
a blast-induced mTBI 
The number and role of females in the military have recently drastically 
expanded, along with their participation in contact sports, thus putting females at increased 
risk of suffering a mTBI (Colvin et al., 2009; Street et al., 2009). Concerns have been raised 
about possible gender-specific differences after some studies have shown that females suffer 
more concussions and report more post-concussive symptoms at three months following a 
mTBI (Bazarian et al., 2010; Colvin et al., 2009; Dick, 2009). Given our findings in Paper I, 
we set out in this study primarily to explore changes in the monoamine systems following a 
single blast exposure in female rats, but we also examined changes in select serum 
biomarkers.  
 
Our examination of forebrain sections for white matter damage, blood vessel 
leakage and degenerating neurones revealed no differences between exposed and sham 
female groups. This is consistent with our findings in the exposed males (Kawa et al., 2014), 
and also with the majority of the blast-induced mTBI literature findings in rodents (Ahlers et 
al., 2012; Kwon et al., 2011; Long et al., 2009a). We also found no significant changes in 
body weight between sham and exposed groups of female rats weighed daily a week before 
and following blast exposure.  
 
Our analysis of TH transcript levels revealed an acute and significant increase 
in female rats bilaterally in the LC, which normalised by 7d post-exposure (Figure 4.5a), 
similar to our previous observations in the males shown in Paper I. The transcript levels of 
the key biosynthetic enzyme TPH2 were also significantly increased at 1d post-exposure, in 
both the mid/caudal and rostral DRN, and remained elevated even at D7. While the acute 
findings in the mid/caudal part of the DRN in the females and males are alike, changes in 
TPH2 transcript levels appeared to be more pronounced and persistent in the females (Figure 
4.5b, c).  
 
Our observations are in line with the literature, specifically that the LC-NA 
system is distinctly activated following stress exposure (Aston-Jones and Cohen, 2005; Korf 
et al., 1973). Furthermore, previous studies looking at TH levels after chronic repeated 
restraint stress have found similar elevations in both males and females (Tóth et al., 2008).  
 
However, our findings in the DRN indicate sex-specific differences, with the 
exposed female group likely more sensitive to the blast exposure. The DRN is a more 
complex nucleus than the LC given that it has a number of distinct sub-regions (Deakin and 
Graeff, 1991), which are modulated by a number of different molecules (Fu et al., 2010; 
Valentino and Commons, 2005). It has been suggested that the sex hormones are also likely 
to influence post-TBI sequelae (Roof and Hall, 2000). Specifically there are oestrogen 
receptors in the DRN, and it has also been shown that 5-HT receptors are oestrogen sensitive 
(Donner and Handa, 2009). Previous studies using rodents have revealed that estradiol 
administration can have anxiolytic effects in female rats (Hiroi et al., 2011). The 
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neuroprotective properties of progesterone have been well established, and its therapeutic 
potential in TBI has been explored (Si et al., 2014). Unfortunately, we were not able to 
delineate the exact contribution of either hormone in this study given the large spread in 
estradiol and progesterone hormone levels across the groups. Thus, the rats were likely at 
different stages of the oestrus cycle.  
 
These findings are particularly relevant in light of clinical reports, where a 
number of studies have specifically identified that female veterans are more likely to suffer 
from depression or PTSD comorbid with depression, while males have higher PTSD rates 
with comorbid substance abuse (Haskell et al., 2011; Iverson et al., 2011; Pugh et al., 2016). 
Our modest findings would implicate the 5-HT systems in this discrepancy between male and 
females. Further support to this idea is leant by previous findings in pre-clinical studies 
suggesting a sex-specific difference in 5-HT metabolism. It is suggested that that females 
have higher levels of 5-HT synthesising enzymes, higher brain and CSF levels of tryptophan, 
5-HT and 5-HIAA compared to males (Carlsson et al., 1985). Furthermore, plasma analysis 
of tryptophan in major depressed females was found to be lower than males, and correlated 
negatively with self-rated depression only in the females (Maes et al., 1990).  
 
 
 
Figure 4.5. Comparison between female and male rats. Changes in transcripts for TH and TPH2 in females 
(present study) and for TH and TPH2 in males (Kawa et al., 2014) in the LC (a) and DRN (b, c) are shown.  
 
 
Our examination of a number of markers in the serum of female and male rats 
at 1 post-exposure also revealed some interesting sex-specific differences (Figure 4.6). The 
levels of CORT and substance P (SP) were both elevated, however only in the exposed 
females relative to sham animals (Figure 4.6a, c). While a decrease in BDNF levels was only 
seen in the exposed male group (Figure 4.6b). S100B levels were statistically significantly 
lower in the female rats, compared to males, regardless of exposure, and also when 
comparing the exposed and sham female groups (Figure 4.6d). 
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In the clinical situation an increase in cortisol levels in response to stress is well 
established (Bierhaus et al., 2003; Lucassen et al., 2014). Maes and colleagues have also 
shown that oral administration of 5-hydroxytryptophan (5-HTP, the 5-HT precursor), 
stimulates a high cortisol response, but only in major depressed females, not males (Maes et 
al., 1987). A likely interpretation of this increase in cortisol may be due to the sensitivity of 
the hypothalamic-pituitary-adrenal axis to 5-HTP; this is interesting as it directly links 
changes in the CNS to the periphery. In the TBI field researchers are eagerly looking for 
biomarkers to objectively diagnose and follow the progression of this disease. Thus, it is of 
great interest to see how faithfully changes in markers in the periphery could reflect changes 
in the CNS.  
High SP levels in the serum of patients with severe TBI have reportedly 
correlated with increased mortality (Lorente et al., 2015). Elevated SP serum levels have also 
been reported in patients with major depression, levels that decline in responders treated with 
antidepressant (Bondy et al., 2003). SP antagonists have also been used preclinically to 
alleviate TBI pathology, and it has done so both in male and female rats (Corrigan et al., 
2012; Donkin et al., 2011).  
 
 
Figure 4.6. Serum analysis of several markers in female vs males at 1 d following blast exposure. (a) 
CORT levels were increased in the female exposed group. (b) BDNF was decrease in the exposed males. (c) 
Substance P was increased in the female exposed group only. (d) Changes in S100B levels included a 
decreased in female relative to male groups regardless of exposure.  
Data are presented as mean ± SEM. (Independent t-test; * p <0.05, ** p <0.01, ANOVA; ¤ p <0.05, ¤¤¤¤ p 
<0.0001).  
CORT; Corticosterone, BDNF; brain-derived neurotrophic factor, S100B; calcium-binding protein β,  ELISA; 
enzyme-linked immunosorbent assay. 
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5 GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
The injury mechanism of TBI contains the primary injury process caused by the 
physical forces and occurs immediately after the insult as structural and/or neurochemical 
changes. The secondary injury process represents the biological response to the injury aimed 
to restrict and repair the damage. This process can last for an extended period of time (up to 
weeks and months) and includes metabolic changes, inflammation, etc. Although much has 
been learnt about metabolic changes and inflammation resulting from TBI, little or no 
attention has been payed to the potential involvement of neurotransmitters in mediating the 
injury induced neurobehavioral changes. Initially they can act upon receptors in the central 
and peripheral nervous system to bring about protective and adaptive changes following the 
injury. However, when the altered signalling persists, it can be damaging and have 
pathological consequences.  
 
Taken together the findings of the four studies presented in this thesis implicate 
the NA, 5-HT and galanin system in the pathobiology of blast-induced mTBI. There is a 
translational aspect of this data given the partially different response to injury in males and 
females. In addition, comparing the same outcome measures using two different models of 
single and repeated mbTBI helps to refine the experimental modelling of the injury and to 
identify the window of cerebral vulnerability. 
 
Changes in the DRN/vPAG warrant further research, in light of the persistent 
elevations in TPH2 transcript levels in the females, and of the increased and decreased GalR1 
and 2 transcript levels, respectively, in the same region in the males. It would be very 
interesting to identify, if changes in the galanin receptor levels are similarly affected in 
females in this region. In fact some preliminary findings in our laboratory indicate sex-
specific differences in galanin levels in the brainstem (preliminary observations not included 
in this thesis). Also sex-specific differences have been described in depressed suicides, 
specifically GalR1 was found only elevated in males, while GalR3 was elevated in both 
genders, but more robustly in females (Barde et al., 2016), indicating a translational potential 
of our findings. Such distinct sex-specific differences may be crucial in developing more 
efficacious therapy targeted to the specific genders.  
 
Also given the extensive association between galanin and the monoamine 
systems, combination therapies targeting both systems may have a better therapeutic 
potential. Although here one needs to cautiously translate these findings from rodents to 
humans given that galanin receptors subtype distribution appears to be species specific (Le 
Maître et al., 2013). In the rat GalR1/2 are the dominate receptors in the brainstem, while in 
humans GalR3 appears to be important (Le Maître et al., 2013). Although, both receptors 
signal through an inhibitory G-protein subunit, and hence are likely to have similar effects 
(Lang et al., 2015).  
  
  43 
The NA, 5-HT, and galanin extensively innervate forebrain regions and play 
key roles in limbic circuits. If these systems are dysregulated, as the studies in this thesis 
suggest, then they may likely cause deficits in concentration, attention, memory, arousal, 
sleep regulation, mood, and anxiety, leading to much of the symptomology described in PCS 
and PTSD in affected populations.  
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